Introducing the Seretide Metered Dose Inhaler, a reliable solution for managing asthma and chronic obstructive pulmonary disease (COPD). This inhaler combines Fluticasone Propionate and Salmeterol Xinafoate to provide effective relief and control of respiratory symptoms.
Key FeaturesIdeal for individuals with asthma or COPD requiring regular maintenance therapy.
Typical User ProfileAdults and adolescents aged 12 years and older with respiratory conditions.
About the BrandGlaxoSmithKline is a leader in respiratory health, known for pioneering innovative treatments and therapies to improve patient outcomes.